Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Gabapentin Market, by Application
1.4.2 Europe Gabapentin Market, by Dosage Form
1.4.3 Europe Gabapentin Market, by Distribution Channel
1.4.4 Europe Gabapentin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Gabapentin Market by Application
3.1 Europe Epilepsy Market by Country
3.2 Europe Restless Legs Syndrome Market by Country
3.3 Europe Neuropathic Pain Market by Country
3.4 Europe Others Market by Country
Chapter 4. Europe Gabapentin Market by Dosage Form
4.1 Europe Capsule Market by Country
4.2 Europe Tablet Market by Country
4.3 Europe Oral Solution Market by Country
Chapter 5. Europe Gabapentin Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country
Chapter 6. Europe Gabapentin Market by Country
6.1 Germany Gabapentin Market
6.1.1 Germany Gabapentin Market by Application
6.1.2 Germany Gabapentin Market by Dosage Form
6.1.3 Germany Gabapentin Market by Distribution Channel
6.2 UK Gabapentin Market
6.2.1 UK Gabapentin Market by Application
6.2.2 UK Gabapentin Market by Dosage Form
6.2.3 UK Gabapentin Market by Distribution Channel
6.3 France Gabapentin Market
6.3.1 France Gabapentin Market by Application
6.3.2 France Gabapentin Market by Dosage Form
6.3.3 France Gabapentin Market by Distribution Channel
6.4 Russia Gabapentin Market
6.4.1 Russia Gabapentin Market by Application
6.4.2 Russia Gabapentin Market by Dosage Form
6.4.3 Russia Gabapentin Market by Distribution Channel
6.5 Spain Gabapentin Market
6.5.1 Spain Gabapentin Market by Application
6.5.2 Spain Gabapentin Market by Dosage Form
6.5.3 Spain Gabapentin Market by Distribution Channel
6.6 Italy Gabapentin Market
6.6.1 Italy Gabapentin Market by Application
6.6.2 Italy Gabapentin Market by Dosage Form
6.6.3 Italy Gabapentin Market by Distribution Channel
6.7 Rest of Europe Gabapentin Market
6.7.1 Rest of Europe Gabapentin Market by Application
6.7.2 Rest of Europe Gabapentin Market by Dosage Form
6.7.3 Rest of Europe Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
Unique Offerings 
